Performance of BOADICEA and BRCAPRO genetic models and of empirical criteria based on cancer family history for predicting BRCA mutation carrier probabilities: A retrospective study in a sample of Italian cancer genetics clinics
Liliana Varesco(Istituti di Ricovero e Cura a Carattere Scientifico), L Bonelli(Ospedale Policlinico San Martino), Elisa Alducci(Istituto Oncologico Veneto), Daniela Turchetti(University of Bologna), Stefania Tommasi(Istituto Tumori Bari), Monica Zuradelli(Humanitas University), Paolo Bruzzi(Alleanza Contro il Cancro), Paola Mandich(University of Genoa), Cristina Oliani(Ospedale Maggiore), Viviana Gismondi(University of Siena), Marco Montagna(Azienda Ospedale - Università Padova), R. Bracci(Ospedali Riuniti di Ancona), Daniela Boggiani(University of Parma), Caterina Vivanet(University of Cagliari), Valeria Viassolo(University of Siena), Paolo Radice(IFOM), Pietro Cavalli(Istituti Ospitalieri di Cremona), Maria Grazia Tibiletti(University of Insubria), Maria A. Caligo(Azienda Ospedaliera Universitaria Pisana), Alessandra Viel(Centro di Riferimento Oncologico), Lara Della Puppa(National Cancer Institute)
Cited by 22
Related Papers
Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database
|Genetics in Medicine|2019|666
Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses
|Nature Genetics|2020|580
Different Genetic Features Associated with Colon and Rectal Carcinogenesis
|Clinical Cancer Research|2004|228
<i>PALB2</i>, <i>CHEK2</i> and <i>ATM</i> rare variants and cancer risk: data from COGS
|Journal of Medical Genetics|2016|217